Inherited levels of A and B types of monoamine oxidase activity - PubMed (original) (raw)
Inherited levels of A and B types of monoamine oxidase activity
X O Breakefield et al. Schizophr Bull. 1980.
Abstract
In establishing the role of inherited variations in levels of monoamine oxidase (MAO) activity in neuropsychiatric diseases, it is important to measure levels of both A and B types of activity as they appear to be under separate genetic control. Levels of A and B types of activity can be evaluated in fibroblasts and platelets, respectively. A number of genes could be involved in determining levels of activity, including those coding for the catalytic and noncatalytic subunits of the enzyme, as well as those coding for enzymes involved in covalent attachment of the flavin cofactor, other processing steps, degradation of MAO, and lipid metabolism. Different genes may be critical in controlling activity levels in various cell types depending on differential expression of the genome. In order to establish the molecular basis of variation in activity, techniques should be employed to assess the structure and conformation of the enzyme, as well as the number of enzyme molecules and their interaction with other cellular components. Only by understanding the genetic and environmental factors controlling levels of A and B types of MAO activity can we hope to evaluate and manipulate the role of MAO in human neurophysiology.
Similar articles
- Platelet monoamine oxidase as a function of nongenetic factors.
Friedhoff AJ, Miller JC. Friedhoff AJ, et al. Schizophr Bull. 1980;6(2):314-9. doi: 10.1093/schbul/6.2.314. Schizophr Bull. 1980. PMID: 6103576 - Monoamine oxidase (MAO) activity as a determinant in human neurophysiology.
Pintar JE, Breakefield XO. Pintar JE, et al. Behav Genet. 1982 Feb;12(1):53-68. doi: 10.1007/BF01065740. Behav Genet. 1982. PMID: 6284115 - Platelet monoamine oxidase values and genetic heterogeneity in schizophrenia research.
Baron M, Levitt M, Perlman R. Baron M, et al. JAMA. 1981 Sep 25;246(13):1418-21. JAMA. 1981. PMID: 7265444 - Modulation of monoamine oxidase (MAO) expression in neuropsychiatric disorders: genetic and environmental factors involved in type A MAO expression.
Naoi M, Riederer P, Maruyama W. Naoi M, et al. J Neural Transm (Vienna). 2016 Feb;123(2):91-106. doi: 10.1007/s00702-014-1362-4. Epub 2015 Jan 22. J Neural Transm (Vienna). 2016. PMID: 25604428 Review. - Platelet monoamine oxidase activity in schizophrenia: a review of the data.
Wyatt RJ, Potkin SG, Murphy DL. Wyatt RJ, et al. Am J Psychiatry. 1979 Apr;136(4A):377-85. Am J Psychiatry. 1979. PMID: 371419 Review.
Cited by
- Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia.
Glatt SJ, Everall IP, Kremen WS, Corbeil J, Sásik R, Khanlou N, Han M, Liew CC, Tsuang MT. Glatt SJ, et al. Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15533-8. doi: 10.1073/pnas.0507666102. Epub 2005 Oct 13. Proc Natl Acad Sci U S A. 2005. PMID: 16223876 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical